Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-29

Clinical Trial Update: Specificity of Dyspnoea Relief With Inhaled Furosemide [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether inhaled furosemide provides specific relief of dyspnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: Oxford Brookes University | Conditions: Dyspnea | Phase 1 | Status: COMPLETED